434 related articles for article (PubMed ID: 25759401)
1. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
Winstock A; Lynskey M; Borschmann R; Waldron J
J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401
[TBL] [Abstract][Full Text] [Related]
2. Safety issues concerning the medical use of cannabis and cannabinoids.
Ware MA; Tawfik VL
Pain Res Manag; 2005; 10 Suppl A():31A-7A. PubMed ID: 16237480
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
4. A survey of synthetic cannabinoid consumption by current cannabis users.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
[TBL] [Abstract][Full Text] [Related]
5. Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington.
Davis KC; Allen J; Duke J; Nonnemaker J; Bradfield B; Farrelly MC; Shafer P; Novak S
PLoS One; 2016; 11(1):e0146853. PubMed ID: 26800209
[TBL] [Abstract][Full Text] [Related]
6. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.
Winstock AR; Barratt MJ
Hum Psychopharmacol; 2013 Jul; 28(4):390-3. PubMed ID: 23881887
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use in people with severe mental illness: The association with physical and mental health--a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study.
Bruins J; Pijnenborg MG; Bartels-Velthuis AA; Visser E; van den Heuvel ER; Bruggeman R; Jörg F
J Psychopharmacol; 2016 Apr; 30(4):354-62. PubMed ID: 26883305
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
[TBL] [Abstract][Full Text] [Related]
10. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
11. Cannabis, cannabinoids, and health.
Lafaye G; Karila L; Blecha L; Benyamina A
Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
[TBL] [Abstract][Full Text] [Related]
12. The adverse health effects of chronic cannabis use.
Hall W; Degenhardt L
Drug Test Anal; 2014; 6(1-2):39-45. PubMed ID: 23836598
[TBL] [Abstract][Full Text] [Related]
13. Do police arrestees substitute legal highs for other drugs?
Wilkins C; Parker K; Prasad J; Jawalkar S
Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
[TBL] [Abstract][Full Text] [Related]
14. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.
Clayton HB; Lowry R; Ashley C; Wolkin A; Grant AM
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289138
[TBL] [Abstract][Full Text] [Related]
15. Recreational cannabinoid use: The hazards behind the "high".
Wright S; Metts J
J Fam Pract; 2016 Nov; 65(11):770-779. PubMed ID: 28087865
[TBL] [Abstract][Full Text] [Related]
16. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
Cohen K; Weizman A; Weinstein A
Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
[TBL] [Abstract][Full Text] [Related]
17. Marijuana: modern medical chimaera.
Lamarine RJ
J Drug Educ; 2012; 42(1):1-11. PubMed ID: 22873011
[TBL] [Abstract][Full Text] [Related]
18. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
[TBL] [Abstract][Full Text] [Related]
19. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample.
Winstock AR; Barratt MJ
Drug Alcohol Depend; 2013 Jul; 131(1-2):106-11. PubMed ID: 23291209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
